Skip to main content
Have a personal or library account? Click to login
Development of human cell biosensor system for genotoxicity detection based on DNA damage-induced gene expression Cover

Development of human cell biosensor system for genotoxicity detection based on DNA damage-induced gene expression

Open Access
|Mar 2010

References

  1. Elespuru RK, Agarwal R, Atrakchi AH, Bigger CAH, Heflich RH, Jagannath DR, et al. Current and Future Application of Genetic Toxicity Assays: The Role and Value of In Vitro Mammalian Assays.2009;: 172-9.
  2. Sutton MD, Smith BT, Godoy VG, Walker GC. The SOS response: Recent insights into umuDC-dependent mutagenesis and DNA damage tolerance.2000;: 479-97.
  3. Putnam CD, Jaehnig EJ, Kolodner RD. Perspectives on the DNA damage and replication checkpoint responses in Saccharomyces cerevisiae.2009;: 974-82.
  4. Holbrook NJ, Fornace AJ. Response to adversity - molecular control of gene activation following genotoxic stress.1991;: 825-33.
  5. Quillardet P, Huisman O, Dari R, Hofnung M. SOS chromotest, a direct assay of induction of an sos function in escherichia-coli k-12 to measure genotoxicity.1982;: 5971-5.
  6. Oda Y, Nakamura S, Oki I, Kató T, Shinagawa H. Evaluation of the new system (umu-test) for the detection of environmental mutagens and carcinogens.1985;: 219-29.
  7. Walmsley RM, Billinton N, Walsh L, Barker MG, Knight AW, Cahill PA. A yeast RAD54-GFP genotoxicity assay, is effective in identifying direct acting mutagens in addition to clastogens not detected by bacterial tests.2003;: 1106.
  8. Liu X, Kramer JA, Swaffield JC, Hu Y, Chai G, Wilson AGE. Development of a highthroughput yeast-based assay for detection of metabolically activated genotoxins.2008;: 63-9.
  9. Zhou B-BS, Elledge SJ. The DNA damage response: putting checkpoints in perspective.2000;: 433-9.
  10. Sionov RV, Haupt Y. The cellular response to p53: the decision between life and death.1999;: 6145-57.
  11. Waldman T, Kinzler KW, Vogelstein B. P21 is necessary for the P53-mediated G1 arrest in human cancer cells.1995;: 5187-90.
  12. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network.2000;: 307-10.
  13. Moldovan G-L, Pfander B, Jentsch S. PCNA, the maestro of the replication fork.2007;: 665-79.
  14. Park SY, Lee SM, Ye SK, Yoon SH, Chung MH, Choi J. Benzo[a]pyrene-induced DNA damage and p53 modulation in human hepatoma HepG2 cells for the identification of potential biomarkers for PAH monitoring and risk assessment.2006;: 27-33.
  15. Zegura B, Zajc I, Lah TT, Filipic M. Patterns of microcystin-LR induced alteration of the expression of genes involved in response to DNA damage and apoptosis.2008;: 615-23.
  16. Hreljac I, Zajc I, Lah T, Filipic M. Effects of model organophosphorous pesticides on DNA damage and proliferation of HepG2 cells.2008;: 360-7.
  17. Ellinger-Ziegelbauer H, Stuart B, Wahle B, Bomann W, Ahr HJ. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver.2005;: 61-84.
  18. Knasmuller S, Mersch-Sundermann V, Kevekordes S, Darroudi F, Huber WW, Hoelzl C,. Use of human-derived liver cell lines for the detection of environmental and dietary genotoxicants; current state of knowledge.2004;: 315-28.
  19. Bressac B, Galvin KM, Liang TJ, Isselbacher KJ, Wands JR, Ozturk M. Abnormal structure and expression of p53 gene in human hepatocellular-carcinoma.1990;: 1973-7.
  20. Mesojednik S, Kamensek U, Cemazar M. Evaluation of shRNA-mediated gene silencing by electroporation in LPB fibrosarcoma cells.2008;: 82-92.
  21. Todd MD, Lee MJ, Williams JL, Nalezny JM, Gee P, Benjamin MB, et al. The cat-tox (l) assay - a sensitive and specific measure of stress-induced transcription in transformed human liver-cells.1995;: 118-28.
  22. Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, et al. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage.2000;: 42-9.
  23. Guittet O, Hakansson P, Voevodskaya N, Fridd S, Graslund A, Arakawa H, et al. Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells.2001;: 40647-51.
  24. Ohno K, Tanaka-Azuma Y, Yoneda Y, Yamada T. Genotoxicity test system based on p53R2 gene expression in human cells: Examination with 80 chemicals.2005;: 47-57.
  25. Ohno K, Ishihata K, Tanaka-Azuma Y, Yamada T. A genotoxicity test system based on p53R2 gene expression in human cells: Assessment of its reactivity to various classes of genotoxic chemicals.2008;: 27-35.
  26. Siafakas RA, Richardson DR. Growth arrest and DNA damage-45 alpha (GADD45α).2009;: 986-9.
  27. Hastwell PW, Chai LL, Roberts KJ, Webster TW, Harvey JS, Rees RW, et al. High-specificity and high-sensitivity genotoxicity assessment in a human cell line: Validation of the GreenScreen HC GADD45a-GFP genotoxicity assay.2006;: 160-75.
  28. Birrell L, Cahill P, Hughes C, Tate M, Walmsley RM. GADD45a-GFP GreenScreen HC assay results for the ECVAM recommended lists of genotoxic and non-genotoxic chemicals for assessment of new genotoxicity tests.2010;: 87-95.
  29. Zhang R, Niu YJ, Do HR, Cao XW, Shi D, Hao QL, et al. A stable and sensitive testing system for potential carcinogens based on DNA damage-induced gene expression in human HepG2 cell.2009;: 158-65.
  30. Yang TT, Cheng LZ, Kain SR. Optimized codon usage and chromophore mutations provide enhanced sensitivity with the green fluorescent protein.1996;: 4592-3.
  31. Cormack BP, Valdivia RH, Falkow S. FACS-optimized mutants of the green fluorescent protein (GFP).1996;: 33-8.
  32. Lawley PD. Mutagens as carcinogens - development of current concepts.1989;: 3-25.
  33. Beranek DT. Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating-agents.1990;: 11-30.
  34. Jaiswal AS, Narayan S. S(N)2 DNA-alkylating agent-induced phosphorylation of p53 and activation of p21 gene expression.2002;: 17-30.
  35. Perlow RA, Kolbanovskii A, Hingerty BE, Geacintov NE, Broyde S, Scicchitano DA. DNA adducts from a tumorigenic metabolite of benzo[a]pyrene block human RNA polymerase II elongation in a sequence- and stereochemistry-dependent manner.2002;: 29-47.
  36. Wang A, Gu J, Judson-Kremer K, Powell KL, Mistry H, Simhambhatla P, et al. Response of human mammary epithelial cells to DNA damage induced by BPDE: involvement of novel regulatory pathways.2003;: 225-34.
  37. Sadikovic B, Rodenhiser DI. Benzopyrene exposure disrupts DNA methylation and growth dynamics in breast cancer cells.2006;: 458-68.
  38. Jagger C, Tate M, Cahill PA, Hughes C, Knight AW, Billinton N, et al. Assessment of the genotoxicity of S9-generated metabolites using the GreenScreen HC GADD45a-GFP assay.2009;: 35-50.
  39. Corda Y, Job C, Anin MF, Leng M, Job D. Spectrum of DNA platinum adduct recognition by prokaryotic and eukaryotic DNA-dependent RNA-polymerases.1993;: 8582-8.
  40. Pabla N, Huang S, Mi QS, Daniel R, Dong Z. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.2008;: 6572-83.
  41. Marini F, Nardo T, Giannattasio M, Minuzzo M, Stefanini M, Plevani P,. DNA nucleotide excision repair-dependent signaling to checkpoint activation.2006;: 17325-30.
  42. Owellen RJ, Hartke CA, Dickerson RM, Hains FO. Inhibition of tubulin-microtubule polymerization by drugs of vinca alkaloid class.1976;: 1499-502.
  43. Tishler RB, Lamppu DM, Park S, Price BD. Microtubule-active drugs taxol, vinblastine, and nocodazole increase the levels of transcriptionally active P53.1995;: 6021-5.
DOI: https://doi.org/10.2478/v10019-010-0010-3 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 42 - 51
Published on: Mar 18, 2010
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2010 Valerija Zager, Maja Cemazar, Irena Hreljac, Tamara Lah, Gregor Sersa, Metka Filipic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.